ATE455792T1 - Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon - Google Patents

Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon

Info

Publication number
ATE455792T1
ATE455792T1 AT04805350T AT04805350T ATE455792T1 AT E455792 T1 ATE455792 T1 AT E455792T1 AT 04805350 T AT04805350 T AT 04805350T AT 04805350 T AT04805350 T AT 04805350T AT E455792 T1 ATE455792 T1 AT E455792T1
Authority
AT
Austria
Prior art keywords
sequence
pharmaceutical compositions
binding protein
compositions containing
containing same
Prior art date
Application number
AT04805350T
Other languages
English (en)
Inventor
Eric Chabriere
Carlos Contreras-Martel
Juan Fontecilla-Camps
Original Assignee
Centre Nat Rech Scient
Univ Henri Poincare Nancy I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Henri Poincare Nancy I filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE455792T1 publication Critical patent/ATE455792T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT04805350T 2003-10-30 2004-10-29 Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon ATE455792T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312729A FR2861731B1 (fr) 2003-10-30 2003-10-30 Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
PCT/FR2004/002797 WO2005042572A1 (fr) 2003-10-30 2004-10-29 Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations

Publications (1)

Publication Number Publication Date
ATE455792T1 true ATE455792T1 (de) 2010-02-15

Family

ID=34429758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805350T ATE455792T1 (de) 2003-10-30 2004-10-29 Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon

Country Status (11)

Country Link
US (1) US7718773B2 (de)
EP (1) EP1678204B1 (de)
JP (1) JP4728246B2 (de)
CN (1) CN1898261B (de)
AT (1) ATE455792T1 (de)
CA (1) CA2543935C (de)
DE (1) DE602004025265D1 (de)
ES (1) ES2341174T3 (de)
FR (1) FR2861731B1 (de)
IL (1) IL175319A (de)
WO (1) WO2005042572A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP1968630B1 (de) 2005-12-29 2018-01-24 Boehringer Ingelheim Vetmedica, Inc. Multivalente immunogene pcv2-zusammensetzungen
EP2099927A4 (de) * 2006-11-22 2010-05-05 Boehringer Ingelheim Vetmed Verfahren zur reduzierung von mit schweine-circovirus assoziierten krankheitsausbrüchen
EP2859900A1 (de) * 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Wirksames Verfahren zur Behandlung von Infektionen mit dem porcinen Circovirus und Lawsonia intracellularis
JP5200223B2 (ja) * 2006-12-15 2013-06-05 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド Ｐｃｖ２抗原によるブタの処置
EP1941903A1 (de) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
WO2009088950A2 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
KR20100113582A (ko) * 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
FR2942717B1 (fr) * 2009-03-04 2011-08-12 Centre Nat Rech Scient Nouvel agent antiviral
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
US20140018288A1 (en) * 2012-07-16 2014-01-16 St. Luke's-Roosevelt Hospital Center X-DING-CD4 Peptide
US9505808B2 (en) 2013-10-02 2016-11-29 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 protein variant and virus like particles composed thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999066321A2 (en) * 1998-06-12 1999-12-23 University Of Guelph Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents
US20030158115A1 (en) * 2000-03-28 2003-08-21 Toback F. Gary Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells

Also Published As

Publication number Publication date
CN1898261A (zh) 2007-01-17
EP1678204A1 (de) 2006-07-12
US7718773B2 (en) 2010-05-18
FR2861731A1 (fr) 2005-05-06
CA2543935A1 (fr) 2005-05-12
CN1898261B (zh) 2011-08-17
FR2861731B1 (fr) 2006-02-24
CA2543935C (fr) 2014-12-02
ES2341174T3 (es) 2010-06-16
DE602004025265D1 (de) 2010-03-11
EP1678204B1 (de) 2010-01-20
IL175319A (en) 2013-07-31
IL175319A0 (en) 2006-09-05
WO2005042572A1 (fr) 2005-05-12
JP4728246B2 (ja) 2011-07-20
JP2008502305A (ja) 2008-01-31
US20070196879A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
IN2014CN02050A (de)
IN2015DN02553A (de)
AU2002305450A1 (en) Proteomimetic compounds and methods
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
MX2008009493A (es) Peptido novedoso y uso del mismo.
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
ATE495247T1 (de) Chromoprotein und fluoroproteine
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
AU2003251728A1 (en) Placental growth factor as a target for the treatment of osteoporosis
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
WO2005086595A3 (ja) テロメアタンパク質ｔｒｆ２ｄｎａ結合ドメイン変異体タンパク質、テロメアｄｎａ変異体及びｔｒｆ２ｄｎａ結合ドメインと二重らせんｄｎａとの複合体構造の利用
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
PT1401871E (pt) Moleculas de ligacao imunologicas que inibem a fusao sincicial de celulas do tropoblasto
WO2009014160A1 (ja) 膵癌の新規腫瘍マーカー
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2003087352A3 (en) Enolase polypeptides and structures
WO2005087809B1 (en) Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion
DE60312497D1 (de) Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika
NZ603077A (en) Biological materials and uses thereof
WO2004042044A3 (en) Crystal structures of bacterial guanylate kinases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties